Table 1.
Baseline Participant Demographic and Clinical Characteristics
| Variablea | Sequence Positive (N = 55) | Sequence Negative (N = 71) | p-value |
|---|---|---|---|
| AGE | 57 years (30 −85) | 60 years (35–86) | 0..22 |
| BMI | 28 kg/m2 (21–44) | 27 kg/m2 (16–70) | 0.25 |
| RACE | Caucasian= 50 (91%) African American = 3(6%) Latina =1 (2%) Other = 1 (2%) |
Caucasian= 61 (86%) African American = 3(4%) Latina =1 (1%) Asian = 4 (6%) Other = 2 (3%) |
0.49 |
| POP/UI surgery | POP = 21 (38%) UI = 14 (26%) POP/UI = 20 (36%) |
POP = 27 (38%) UI = 19 (27%) POP/UI = 25 (35%) |
0.98 |
| Diabetes | 0 | 3 (4%) | 0.12 |
| HTN | 19 (35%) | 17 (24%) | 0.19 |
| Coronary Artery Disease | 4 (7%) | 5 (7%) | 0.96 |
| Smoking | 2 (4%) | 0 | 0.11 |
| Hormone Status | Premenopausal = 18 (33%) Postmenopausal on hormones = 7 (13%) Postmenopausal no hormones = 30 (55%) |
Premenopausal = 18 (25%) Postmenopausal on hormones = 12 (17%) Postmenopausal no hormones = 41 (58%) |
0.61 |
| OABq SS preop | 40.5 (10–95) | 32.1 (0–82.5) | 0.03 |
| OABq SS postop | 15.6 (0–77.5) | 15.2 (0–85) | 0.89 |
| OABq SS difference | −24.8 (−87.5–62.5) | −16.9 (−75–37.5) | 0.06 |
| UDI | Preop = 107.52 (±51) Postop = 28.85 (±33) Difference = −78.67 (±51) |
Preop = 99.10 (±52) Postop = 27.93 (±27) Difference = 71.18 (±54) |
0.37 0.86 0.43 |
| POPDI | Preop = 113.36 (±71) Postop = 26.76 (±32) Difference = −86.59 (±64) |
Preop =103.51 (±69) Postop =24.76 (±28) Difference = −78.67 (±68) |
0.43 0.71 0.50 |
| CRADI | Preop = 83.62 (±85) Postop = 32.16 (±43) Difference = −44.54 (±73) |
Preop = 103.51 (±71) Postop =31.15 (±35) Difference = −47.61 (±62) |
0.73 0.89 0.80 |
a
Abbrevations: BMI, body mass index; HTN, hypertension; OABqSS, OABq Symptom Severity; UDI, Urinary Distress Index; POPDI, Pelvic Organ Prolapse Distress Inventory; CRADI, Colorectal Anal Distress Inventory.
b
p-values < 0.05 are considered significant; significant value is bolded.